Health Claims & Product Disclaimer
KOVA Daily Strength is a dietary supplement. This page explains what it is, what is in it, how to use it safely, and the basis for the statements we make about it.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
What KOVA Daily Strength is — and what it is not
KOVA Daily Strength is a dietary supplement, not a drug, medical device, or therapeutic product. It is not intended to diagnose, treat, cure, or prevent any disease or health condition. Nothing on this website, in our packaging, or in our marketing should be interpreted as medical advice.
If you have a diagnosed medical condition, take prescription medication, are pregnant or breastfeeding, or have any health concern relating to the ingredients in KOVA, consult a qualified healthcare professional before use.
KOVA Daily Strength is a daily dietary supplement in sachet form, providing creatine monohydrate, magnesium bisglycinate, vitamin D3 (cholecalciferol), vitamin K2 (as MK-7), folate (as 5-MTHF, Quatrefolic®), and vitamin B12 (methylcobalamin). It is designed to be dissolved in water, coffee, a smoothie, or any cold or warm (not boiling) liquid and consumed once daily.
KOVA products are dietary supplements regulated by the U.S. Food and Drug Administration (FDA) under the Dietary Supplement Health and Education Act of 1994 (DSHEA). As dietary supplements, they are not drugs: they do not require a prescription and are not FDA-approved to treat any condition. Statements about the product are limited to how its ingredients affect the normal structure or function of the body.
Our ingredients
KOVA Daily Strength contains six active ingredients. Each is present at a daily dose within recommended safe intake levels, and the statements we make about them are limited to their effect on the normal structure or function of the body.
Creatine monohydrate
Our creatine monohydrate is a high-purity grade (99.95% creatine monohydrate). Every batch is independently tested by Eurofins, an accredited third-party laboratory, for identity, purity, heavy metals, microbiological safety, and banned-substance contamination, and a Certificate of Analysis is available on request.
Magnesium bisglycinate
Magnesium bisglycinate is a chelated form of magnesium bound to two glycine molecules, selected for its gastrointestinal tolerability and absorption profile compared with inorganic magnesium salts. Each daily sachet provides 56 mg of magnesium (13% of the U.S. Daily Value of 420 mg).
Vitamin D3 (cholecalciferol)
Each daily sachet provides 50 mcg (2000 IU) of vitamin D3 as cholecalciferol, from a vegan, lichen-derived source — 250% of the U.S. Daily Value (20 mcg / 800 IU). This dose is well within the Tolerable Upper Intake Level of 100 mcg (4000 IU) per day for adults. See Section 07 for dose context.
Vitamin K2 (as MK-7)
Each daily sachet provides 180 mcg of vitamin K2 as menaquinone-7 (MK-7), 150% of the U.S. Daily Value for vitamin K (120 mcg). Vitamin K2 works alongside vitamin D and calcium and supports the maintenance of normal bones.
Folate (as 5-MTHF — Quatrefolic®)
Each daily sachet provides 400 mcg DFE of folate as 5-MTHF (the active, body-ready form), 170% of the U.S. Daily Value. It is supplied as Quatrefolic®, a registered trademark of Gnosis by Lesaffre.
Vitamin B12 (methylcobalamin)
Each daily sachet provides 500 mcg of vitamin B12 as methylcobalamin, the bioactive coenzyme form of B12. This is well above the U.S. Daily Value (2.4 mcg); B12 has no established upper limit and excess intake is not stored.
The statements we make about our ingredients
In the United States, dietary supplements may carry "structure/function" statements that describe how a nutrient affects the normal structure or function of the body. They may not claim to diagnose, treat, cure, or prevent any disease. The statements we make are limited to the kind shown below.
| Statement (structure/function) | Ingredient(s) |
|---|---|
| Helps supply energy to working muscle during short bursts of high-intensity activity | Creatine monohydrate |
| Supports normal muscle function | Magnesium · Vitamin D |
| Supports normal energy-yielding metabolism | Magnesium · Vitamin B12 |
| Supports the maintenance of normal bones | Magnesium · Vitamin D · Vitamin K2 |
| Supports the normal function of the nervous system | Magnesium · Vitamin B12 |
| Supports normal psychological function | Magnesium · Vitamin B12 |
| Supports the normal function of the immune system | Vitamin D |
| Supports normal cell division | Folate · Vitamin B12 |
| Supports the normal formation of red blood cells | Folate · Vitamin B12 |
| Supports normal absorption and utilisation of calcium | Vitamin D |
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
What we can and cannot claim
U.S. law draws a strict line between permitted structure/function statements and prohibited disease claims. The following documents that boundary as it applies to KOVA.
Where KOVA's website, email, or social media refers to the science of creatine or the other nutrients in areas such as women's health, cognition, or bone health, that content is presented as educational information about the state of published research — not as a claim by KOVA about what its product will do for you. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Safe use — dosage, duration & precautions
5.1 Recommended daily use
Dissolve one sachet (one daily dose) in 250–300 ml of cold water, coffee, tea, a smoothie, or any other beverage. Stir or shake until fully dissolved. Consume once per day, preferably at the same time each day to build a consistent daily habit. Do not exceed one sachet per day unless advised by a healthcare professional.
Creatine monohydrate: 5 g · Magnesium: 56 mg (13% DV) · Vitamin D3: 50 mcg / 2000 IU (250% DV) · Vitamin K2 (MK-7): 180 mcg (150% DV) · Folate (5-MTHF): 400 mcg DFE (170% DV) · Vitamin B12: 500 mcg
Dietary supplements should not replace a varied, balanced diet and a healthy lifestyle.
5.2 Creatine and water intake
Creatine draws water into muscle cells as part of its mechanism of action. We recommend increasing your daily water intake by approximately 250–500 ml while taking KOVA Daily Strength, particularly during periods of regular exercise. This is not a safety concern — it is a practical recommendation to support the product’s efficacy and to avoid any sensation of mild bloating, which some users experience in the first 1–2 weeks of use.
5.3 Who should consult a doctor before use
- Pregnant or breastfeeding women — the safety of creatine supplementation during pregnancy and lactation has not been sufficiently studied in humans. We recommend consulting your GP or midwife before use.
- Persons with renal impairment or a history of kidney disease — creatine is metabolised and excreted via the kidneys. If you have been diagnosed with any degree of renal impairment or have a family history of kidney disease, consult your doctor before use.
- Persons taking prescription medication — if you are taking any prescription medication, particularly diuretics, nephrotoxic drugs, or any medication affecting renal function, consult your prescribing doctor before use.
- Persons with diabetes — creatine may affect blood glucose regulation in some individuals. If you have type 1 or type 2 diabetes, consult your doctor before use.
- Persons with a history of liver disease — while no evidence of hepatotoxicity from creatine supplementation at normal doses exists in healthy adults, consult your doctor if you have a diagnosed liver condition.
5.4 Not for children
KOVA Daily Strength is formulated for adults aged 18 and over. Keep out of reach of children. The safety of creatine supplementation in children and adolescents has not been established, and we do not recommend use in persons under 18.
5.5 Adverse effects and interactions
Creatine monohydrate at the doses used in KOVA Daily Strength (5 g/day) is considered safe for healthy adults based on extensive peer-reviewed literature. The most commonly reported minor side effects in a small proportion of users are mild gastrointestinal discomfort (nausea, stomach cramping, or loose stools) during the first 1–2 weeks of use. These effects typically resolve without intervention as the body adjusts.
If you experience any serious or persistent adverse effect that you believe may be associated with KOVA Daily Strength, discontinue use and consult a healthcare professional. Please also report the adverse effect to us at hello@takekova.com, and to the U.S. FDA via MedWatch at fda.gov/safety/medwatch or 1-800-FDA-1088.
Allergens & product composition
6.1 Allergen declaration
KOVA Daily Strength does not contain any of the 9 major food allergens identified under U.S. law (the Food Allergen Labeling and Consumer Protection Act, as amended by the FASTER Act) as intentional ingredients: milk, eggs, fish, crustacean shellfish, tree nuts, peanuts, wheat, soybeans, and sesame. The product is:
KOVA Daily Strength is made in a facility that also processes other dietary-supplement ingredients. While allergen cleaning protocols are in place, we cannot guarantee the complete absence of trace allergens from cross-contamination. If you have a severe allergy, review the Supplement Facts panel on your product and contact hello@takekova.com for batch-specific information.
6.2 Ingredients
Each KOVA Daily Strength sachet contains: creatine monohydrate, magnesium bisglycinate, vitamin D3 (cholecalciferol, vegan), vitamin K2 (as MK-7), folate (as 5-MTHF, Quatrefolic®), and vitamin B12 (methylcobalamin), together with any carriers or anti-caking agents listed on the label.
The complete Supplement Facts panel and ingredient list is printed on every product sleeve and sachet. The label on your product is the definitive ingredient reference for your specific batch. If there is any discrepancy between the website and the physical label, the physical label takes precedence.
6.3 Heavy metals and contaminants
Every batch of KOVA Daily Strength is independently tested by Eurofins, an accredited third-party laboratory, for heavy metals (lead, arsenic, mercury, cadmium), identity, and purity. Our product is manufactured under cGMP (21 CFR Part 111), and a Certificate of Analysis (COA) is available for each batch. Customers, healthcare professionals, or regulators may request the COA for a specific batch by contacting hello@takekova.com with their order number and the batch number printed on the sleeve.
Vitamin D — dose in context
KOVA Daily Strength provides 50 mcg (2000 IU) of vitamin D3 per daily sachet — 250% of the U.S. Daily Value. We disclose the dose context openly because transparency is a core KOVA principle.
Why 2000 IU
The U.S. Daily Value for vitamin D is 20 mcg (800 IU). The Tolerable Upper Intake Level for adults, set by the National Academy of Medicine, is 100 mcg (4000 IU) per day — twice the amount in KOVA. 2000 IU is a commonly used daily maintenance dose in adult supplementation, and vitamin D insufficiency is common, particularly in autumn and winter.
KOVA Daily Strength is intended to be your only vitamin D supplement. If you also take a separate vitamin D supplement or a multivitamin containing vitamin D, make sure your total daily intake from all sources does not exceed 100 mcg (4000 IU). If you are unsure, consult a healthcare professional.
The science behind our claims
This section references published, peer-reviewed research to give educational context for our ingredient choices. It is provided for transparency only. These are summaries of the research landscape — they are not claims by KOVA about what its product will do for you, and individual results vary. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Creatine monohydrate
The body of peer-reviewed research on creatine monohydrate comprises over 500 published studies. The following specific research areas are referenced in KOVA’s communications:
- Physical performance: Smith-Ryan et al. (2021) — Effects of creatine supplementation on exercise performance and fat-free mass in female athletes. Journal of Athletic Training. Demonstrated significant improvements in peak power and lean mass in resistance-trained women supplementing with 5 g creatine monohydrate daily.
- Cognitive function: Rae et al. (2003) — Oral creatine monohydrate supplementation improves brain performance. Proceedings of the Royal Society B: Biological Sciences. Double-blind, placebo-controlled trial showing significant improvement in working memory and intelligence tasks.
- Perimenopause and bone health: Chilibeck et al. (2015) — Effects of creatine and resistance training on bone health in postmenopausal women. Medicine & Science in Sports & Exercise. 52-week RCT showing that creatine supplementation combined with resistance training produced greater improvements in bone mineral content versus resistance training alone.
- Sleep and fatigue: Doherty et al. (2023) — Creatine supplementation reduced sleep deprivation–induced performance decrements and may mitigate the cognitive and physical effects of sleep disruption. Scientific Reports.
- General safety: Kreider et al. (2017) — International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition. Comprehensive review concluding that creatine monohydrate is the most effective ergogenic nutritional supplement currently available and is safe for use in healthy adults.
Magnesium bisglycinate
- Bioavailability: Schuette et al. (1994) — Bioavailability of magnesium diglycinate vs. magnesium oxide in patients with ileal resection. Journal of Parenteral and Enteral Nutrition. Demonstrated superior absorption of chelated magnesium versus inorganic forms in compromised gut environments.
- Sleep quality: Abbasi et al. (2012) — The effect of magnesium supplementation on primary insomnia in elderly: a double-blind, placebo-controlled clinical trial. Journal of Research in Medical Sciences.
Vitamin D3 in women
- Prevalence of deficiency: Cashman et al. (2016) — Vitamin D deficiency in Europe: pandemic? The American Journal of Clinical Nutrition. Found that approximately 13% of EU adults have serum 25(OH)D below 30 nmol/L and 40% below 50 nmol/L year-round.
Full citations and links to source publications are available on our Science page at takekova.com/science. If you are a healthcare professional seeking specific research documentation, contact hello@takekova.com.
Reporting adverse effects
We take reports of adverse effects seriously. As a dietary-supplement company, we investigate reports associated with our products and report serious adverse events to the U.S. Food and Drug Administration (FDA) as required by law.
If you believe you have experienced an adverse effect from KOVA Daily Strength, please:
- Discontinue use of the product.
- Seek medical attention if the effect is serious, persistent, or involves any symptom you are concerned about.
- Contact us at hello@takekova.com with your order number, the batch number (printed on the sleeve and sachet), a description of the effect, when it began, and any other medications or supplements you take.
- Retain the product and its packaging — do not dispose of them before contacting us.
You can also report directly to the FDA:
We commit to acknowledging all adverse-effect reports within 1 business day and to investigating and responding within 10 business days. Where a safety risk is confirmed, we will notify the FDA within the required timeframe and cooperate fully with any recall or market-withdrawal procedure.
Regulatory framework
The following U.S. laws and regulations govern KOVA Daily Strength as a dietary supplement:
| Law / Regulation | Subject | Applies to KOVA |
|---|---|---|
| DSHEA (1994) & the Federal Food, Drug, and Cosmetic Act | Classification and regulation of dietary supplements | KOVA is a dietary supplement, not a drug. It is not FDA-approved to treat any condition; statements are limited to structure/function. |
| FDA 21 CFR Part 111 | Current Good Manufacturing Practice (cGMP) for dietary supplements | KOVA is manufactured under cGMP with batch testing and Certificates of Analysis. |
| FDA 21 CFR 101.36 | Supplement Facts labeling | Every sleeve and sachet carries a Supplement Facts panel and ingredient list. |
| FTC Act & advertising-substantiation standards | Truthful, non-misleading, substantiated advertising claims | Our claims are limited to structure/function statements we can support. |
| FALCPA (as amended by the FASTER Act) | Major food-allergen labeling (9 allergens) | Allergen status is declared; see Section 06. |
| California Proposition 65 | Warnings for certain substances (e.g. heavy metals) for products sold in California | We test for heavy metals and assess any Prop 65 warning obligations for California customers. |
Contact & questions
For any question about our ingredients, health claims, safety documentation, or regulatory compliance:
Product & Compliance Contact
Dietary supplements are not substitutes for a varied, balanced diet and a healthy lifestyle. The information on this page is provided for transparency and regulatory compliance purposes. It does not constitute medical advice. If you have questions about whether KOVA Daily Strength is appropriate for your individual health circumstances, consult a qualified healthcare professional.